SCHEMBL2943880

SCHEMBL2943880

CCC(C(=O)Nc1cc(CN2C(=O)N(c3ccc(C(F)(F)F)cc3S)C(=O)C2(C)C)ccn1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 18/20 0.49
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GAA P10253 1/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2941761 0.88 IGF1R (0.55) IGF1RALDH1A1
SCHEMBL2990255 0.86 IGF1R (0.54) IGF1R
SCHEMBL2943419 0.85 IGF1R (0.55) IGF1R
SCHEMBL2940677 0.84 IGF1R (0.55) IGF1R
SCHEMBL2943878 0.83 IGF1R (0.73) IGF1RGAATHRB
SCHEMBL2992288 0.82 IGF1R (0.49) IGF1RSMN1; SMN2
SCHEMBL2942056 0.82 IGF1R (0.53) IGF1R
SCHEMBL19410374 0.81 IGF1R (0.46) IGF1RALDH1A1SMN1; SMN2GAATHRB
SCHEMBL2995898 0.80 IGF1R (0.51) IGF1RALDH1A1
SCHEMBL2941507 0.79 IGF1R (0.51) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-B1 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA SA (FR) 2010-09-22 EP disclosed
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed